Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Adicet Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 102 | +2 |
| Shares | 38.0M | 21 | 41.5M | +3.56M (+9.4%) |
| Value | $555.9M | $0 | $590.7M | +$34.9M (+6.3%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Adicet Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Adicet Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tri Locum Partners LP | 183,857 | $2.68M |
| Ikarian Capital, LLC | 143,214 | $2.09M |
| Millennium Management LLC | 128,666 | $1.88M |
| Renaissance Technologies LLC | 125,500 | $1.83M |
| Healthcare of Ontario Pension Plan Trust Fund | 104,900 | $1.53M |
| Jackson Creek Investment Advisors LLC | 54,425 | $919.0K |
| Cubist Systematic Strategies, LLC | 44,523 | $650.0K |
| Graham Capital Management, L.P. | 20,890 | $304.0K |
| Panagora Asset Management Inc | 16,805 | $245.0K |
| Engineers Gate Manager LP | 16,760 | $245.0K |
| Group One Trading, L.P. | 15,000 | $219.0K |
| Boothbay Fund Management, LLC | 14,317 | $209.0K |
| Atom Investors LP | 11,772 | $172.0K |
| Jump Financial, LLC | 11,690 | $171.0K |
| Trexquant Investment LP | 10,962 | $160.0K |
| UBS Asset Management Americas Inc | 10,500 | $153.3K |
| Lazard Asset Management LLC | 5,669 | $82.0K |
| High Net Worth Advisory Group LLC | 500 | $7.00K |
| Captrust Financial Advisors | 83 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Adicet Bio, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cordasco Financial Network | 21 | $0 |